[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fXyUC67T_8SjPyQ0NUhQklARLNWxqGuoGY_RMdY-ceas":8,"$ftoo5aRq6D2e-KCWJazvjvIoln_DOrs8fZjJ-qq3Rif4":55,"$f6ZRb8rR6VvIT6e59rDUTu2XU15ueynnOuHjzEWy-Zx8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65706,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"结直肠恶性肿瘤放化疗常用药品安全使用指南","","https://ystcdn.venuertc.com/venue/AI/d6172b62-24d1-4edd-8037-6fbed91ab2f0.jpg","\u003Cdiv class=\"colorectal-drug-guide\">\n  \u003Ch2 id=\"material_title\" class=\"colorectal-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结直肠恶性肿瘤放化疗常用药品安全使用指南\u003C/h2>\n  \n  \u003Cdiv class=\"drugguide-intro\">\n    \u003Cp>\n      说起结直肠恶性肿瘤的治疗，大家常常会听到化疗药、放疗辅助药，以及一些靶向类和免疫调节类药物。虽然名字听起来复杂，但这些药品各有分工。在治疗过程中，如何把这些药品安全、有效地用好？这篇指南将带你逐一解析7个关键用药细节，让你真正做到用药有方法，规避风险不迷糊。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 用药要点一：服用时间和方法 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f0f4f9 60%, #e5eef3 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"usage_time_method\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 服用时间和给药方式 ⏰\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        结直肠恶性肿瘤临床治疗主要涉及两类药品：化疗药（如奥沙利铂、氟尿嘧啶、卡培他滨等）和辅助放疗药物。不同药品对服药时间和使用方法的要求并不一样。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>静脉用药：\u003C/strong>奥沙利铂、伊立替康、氟尿嘧啶等多以静脉滴注为主。应严格按照医院安排静脉输注，过程中须密切监测身体反应。\u003C/li>\n        \u003Cli>\u003Cstrong>口服药物：\u003C/strong>卡培他滨等部分化疗药为片剂或胶囊，通常建议餐前30分钟或餐后2小时口服，有利于减少脱发、恶心等消化系统不良反应。不可随意增减剂量。\u003C/li>\n        \u003Cli>\u003Cstrong>放疗辅助药：\u003C/strong>如需要同步服用化疗药，务必按照指定时间服用，避免和乳制品等高钙食物同时服药。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-important\">正确做法：\u003C/span>服药应遵医嘱，按时服用，切勿因副作用自行停药或更改服药时间。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药要点二：剂型与服用技巧 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f8f9fb 60%, #e6f3fa 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"dosage_form\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型区别与特殊服药技巧 💊\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        结直肠治疗过程中，药品剂型常见有片剂、胶囊、静脉注射液等。每种剂型都有独特的使用方法：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>片剂/胶囊：\u003C/strong>如卡培他滨片剂，吞服时须用足量温水（≥200ml），避免咀嚼或压碎，由于部分药片为肠溶衣，不可打开服用。\u003C/li>\n        \u003Cli>\u003Cstrong>静脉滴注：\u003C/strong>如奥沙利铂溶液需新鲜配制，输注过程中注意防止药液外渗，以减少局部组织损伤。\u003C/li>\n        \u003Cli>\u003Cstrong>特殊制剂：\u003C/strong>有些口服药需要依靠分散剂溶于水，需要搅拌彻底后服用。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-tips\">需要注意：\u003C/span>服药时避免与果汁、茶水或碳酸饮料一同服下，以免影响药效。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药要点三：药理作用大揭秘 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f6f8fc 50%, #e4f4f9 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"mechanism\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药理作用怎么实现？🔬\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        常用化疗药品作用机制各有不同，但都核心目标是阻断异常细胞分裂：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>奥沙利铂：\u003C/strong>通过干扰DNA复制，阻断细胞正常周期，抑制癌细胞增殖。（de Gramont et al., 2000）\u003C/li>\n        \u003Cli>\u003Cstrong>氟尿嘧啶：\u003C/strong>阻断胸苷酸合成，干扰DNA合成进程。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨：\u003C/strong>在体内转化为氟尿嘧啶，发挥同样作用，但主要在肿瘤组织靶向活化。\u003C/li>\n        \u003Cli>\u003Cstrong>伊立替康：\u003C/strong>抑制拓扑异构酶I，引起DNA断裂，阻碍细胞分裂。\u003C/li>\n        \u003Cli>\u003Cstrong>靶向药物（如贝伐单抗）：\u003C/strong>通过抑制新生血管生成，\"饿死\"肿瘤细胞。（Hurwitz et al., 2004）\u003C/li>\n        \u003Cli>\u003Cstrong>免疫检查点抑制剂：\u003C/strong>帮助自身免疫系统更好识别异常细胞。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-note\">补充说明：\u003C/span>这些药品有协同和叠加效果，制定方案通常需要多种药物组合使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药要点四：剂量设置和调整规则 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(110deg, #eef1f8 60%, #e7f3f8 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"dosage_adjustment\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂量如何设置？不同人群须知📏\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        化疗药剂量一般需根据体表面积（BSA）或体重精确计算，部分药物还需结合肝、肾功能与年龄评估。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>标准剂量：\u003C/strong>以奥沙利铂为例，常用剂量为85mg/m\u003Csup>2\u003C/sup>，静脉滴注。\u003C/li>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong>年龄超65岁后，需更谨慎调整，以规避骨髓抑制等风险。临床一例75岁女性在调整剂量后，成功避免严重不良反应。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能不全：\u003C/strong>需根据具体指标减少剂量或延长给药间隔。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童或孕妇：\u003C/strong>极少见，必须严格在医生监控下用药。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-important\">正确做法：\u003C/span>服药前如近期体重有明显波动，务必告知医护，以便及时调整剂量。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药要点五：药物相互作用警惕 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(100deg, #f1f8fb 80%, #dff1fc 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"drug_interactions\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用需要小心👀\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        化疗和放化疗期间常服联合药品，以下几类典型相互作用需特别注意：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>氟尿嘧啶与华法林：\u003C/strong>联用可明显增强抗凝效应，提高出血风险。\u003C/li>\n        \u003Cli>\u003Cstrong>卡培他滨与抗酸药：\u003C/strong>抗酸制剂可能影响药品在体内活化，降低疗效。\u003C/li>\n        \u003Cli>\u003Cstrong>奥沙利铂与氨基糖苷类抗生素：\u003C/strong>联合应用可加重肾毒性及神经毒性。\u003C/li>\n        \u003Cli>\u003Cstrong>免疫抑制剂与激素：\u003C/strong>会影响免疫类药品的疗效。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-tips\">需要注意：\u003C/span>如已服用其他慢性病用药，开始放化疗前必须全面告知医生全部用药清单。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药要点六：常见不良反应与处理措施 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(80deg, #f5f7fb 50%, #deedf7 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"adverse_reactions\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应有哪些？怎么处理？⚠️\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        化疗与放化疗药物副作用多种多样，部分为短期，部分为累计性风险。数据表明，神经毒性、骨髓抑制和消化道反应最常见：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>手足综合征：\u003C/strong>特别见于卡培他滨，表现为手脚刺痛、红肿。可适量冷敷，缓解不适。\u003C/li>\n        \u003Cli>\u003Cstrong>胃肠道反应：\u003C/strong>如恶心、呕吐，常见于氟尿嘧啶。适当调节饮食，多补水，必要时可用止吐药配合。\u003C/li>\n        \u003Cli>\u003Cstrong>骨髓抑制：\u003C/strong>可引发贫血、白细胞减少。用药期间需定期监测血常规，以便及时处理。\u003C/li>\n        \u003Cli>\u003Cstrong>神经毒性：\u003C/strong>奥沙利铂容易引发手指麻木，表现持续加重需及时上报医生。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"tag-important\">正确做法：\u003C/span>遇到严重副作用时，不要擅自停药，应及时联系医生评估调整用药方案。\n      \u003C/p>\n      \u003Cp>\n        临床研究显示，多数化疗相关不良反应在改良给药后可逆，症状严重者不足15%（Andre et al., 2004）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药要点七：储存与服药遗漏应对策略 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(100deg, #f6f9fc 60%, #e6f2fa 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"storage_missed_dose\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存和漏服怎么办？📦\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>储存要求：\u003C/strong>口服制剂需避光、密封、干燥保存，温度不宜超过25℃。静脉用药溶液现配现用，应于24小时内用完，切勿冷冻。\u003C/li>\n        \u003Cli>\u003Cstrong>过期处理：\u003C/strong>过期药品严禁继续使用，建议交由医院药房专门回收。\u003C/li>\n        \u003Cli>\u003Cstrong>漏服措施：\u003C/strong>如漏服口服药，发现后尽快补服，不可一次吞服2倍剂量。若临近下次服用，跳过漏服那次即可。\u003C/li>\n        \u003Cli>\u003Cstrong>特殊提醒：\u003C/strong>静脉治疗建议全程医院管理，如家中自备药品遗失、变质，切勿自行补充，应及时联系医护。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 用药案例集锦（仅聚焦用药本身） -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f0f7fa 60%, #e4f5f9 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"case_studies\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药案例分享📚\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cul>\n        \u003Cli>有位75岁女性患者在使用奥沙利铂和卡培他滨联合方案时，通过密切监测血液参数，成功规避了骨髓抑制风险。\u003C/li>\n        \u003Cli>临床上曾有患者因未按要求餐后服用卡培他滨，导致严重胃肠反应。调整到餐后服用后，反应明显减轻。\u003C/li>\n        \u003Cli>一例辅助治疗中，患者因漏服一次卡培他滨，未自行补服2倍剂量，按指示跳过，未见不良事件。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语与核心提示 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(100deg, #ecf6fa 60%, #e1f3f9 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"summary\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与重点回顾📝\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Cp>\n        结直肠恶性肿瘤放化疗药品覆盖口服和静脉两大类，每种药物服用方法、剂量设定、相互作用和不良反应处理都关系着疗效和安全。记得：\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>每次用药前查清服用方式和最佳时间。\u003C/li>\n        \u003Cli>主动告知医生全部药品清单，警惕药物相互作用。\u003C/li>\n        \u003Cli>持续关注副作用，一旦异常切勿擅自停药。\u003C/li>\n        \u003Cli>药品保存环境和过期处理也需严格遵医嘱。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        用对药、用好药，有效规避风险，提高治疗获益。如有疑问或新药纳入方案，记得咨询专业药师！ \n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"drugguide-section\" style=\"background: linear-gradient(90deg, #f8fbfc 60%, #e4f9f6 100%);\">\n    \u003Ch2 class=\"drugguide-subtitle\" id=\"references\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献及来源📖\u003C/h2>\n    \u003Cdiv class=\"drugguide-content\">\n      \u003Col class=\"drugguide-refs\">\n        \u003Cli>de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., ... &amp; Douillard, J. Y. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 342(23), 1697-1704.\u003C/li>\n        \u003Cli>Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., ... &amp; Berlin, J. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 350(23), 2335-2342.\u003C/li>\n        \u003Cli>Andre, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., ... &amp; de Gramont, A. (2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 350(23), 2343-2351.\u003C/li>\n        \u003Cli>U.S. National Library of Medicine. (2022). Capecitabine. \u003Cem>MedlinePlus\u003C/em>. https://medlineplus.gov/druginfo/meds/a699003.html\u003C/li>\n        \u003Cli>Richard L. Schilsky. (2022). Adverse effects of fluorouracil, leucovorin, and oxaliplatin (FOLFOX). \u003Cem>UpToDate\u003C/em>.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.colorectal-drug-guide {\n    font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n    max-width: 900px;\n    margin: 0 auto;\n    padding: 30px 15px 40px 15px;\n    background: #fafcff;\n    border-radius: 14px;\n    box-shadow: 0 5px 30px rgba(150,160,180,0.08);\n}\n.colorectal-title {\n    text-align: center;\n    color: #234d60;\n    font-size: 2.4em;\n    font-weight: bold;\n    margin-bottom: 40px;\n    letter-spacing: 2px;\n}\n.drugguide-intro {\n    font-size: 1.16em;\n    color: #34495e;\n    background: #f7fafd;\n    border-left: 6px solid #4ac4bb;\n    border-radius: 0 10px 10px 0;\n    padding: 20px 28px;\n    margin-bottom: 38px;\n}\n.drugguide-section {\n    margin-bottom: 38px;\n    border-radius: 13px;\n    padding: 33px 22px 27px 26px;\n    position: relative;\n    /* 背景渐变由行内style控制 */\n}\n.drugguide-subtitle {\n    font-size: 1.37em;\n    margin: 0 0 17px 0;\n    font-weight: 600;\n    color: #206075;\n    letter-spacing: 1.4px;\n    text-shadow: 0 1px 0 #ffffffe6;\n    display: flex;\n    align-items: center;\n    gap: 11px;\n}\n.drugguide-content {\n    font-size: 1.06em;\n    color: #253843;\n    line-height: 1.95;\n}\n.drugguide-content ul,\n.drugguide-content ol {\n    margin: 15px 0 0 25px;\n}\n.drugguide-content li {\n    margin-bottom: 8px;\n    line-height: 1.85;\n}\n.tag-important {\n    display: inline-block;\n    background: #ffdac1;\n    color: #c45122;\n    font-size: 0.98em;\n    border-radius: 6px;\n    padding: 2px 9px;\n    margin-right: 5px;\n}\n.tag-tips {\n    display: inline-block;\n    background: #e3f6f3;\n    color: #067052;\n    font-size: 0.98em;\n    border-radius: 6px;\n    padding: 2px 9px;\n    margin-right: 5px;\n}\n.tag-note {\n    display: inline-block;\n    background: #dbeafe;\n    color: #1d55b9;\n    font-size: 0.97em;\n    border-radius: 6px;\n    padding: 2px 9px;\n    margin-right: 5px;\n}\n.drugguide-refs {\n    font-size: 1em;\n    color: #395367;\n    margin-left: 22px;\n    padding-left: 0;\n}\n@media (max-width: 600px) {\n    .colorectal-title {\n        font-size: 1.49em;\n    }\n    .colorectal-drug-guide {\n        padding: 11px 4px 24px 4px;\n    }\n    .drugguide-section {\n        padding: 18px 7px 13px 9px;\n    }\n    .drugguide-intro {\n        padding: 9px 8px;\n        font-size: 1em;\n    }\n    .drugguide-subtitle {\n        font-size: 1.11em;\n    }\n}\n\u003C/style>\n","\u003Cdiv class=\"colorectal-drug-guide\">\n  \u003Ch2 id=\"material_title\" class=\"colorectal-title\" style=\"color:",458,"2025-09-04 16:35:57","结直肠恶性肿瘤, 化疗药, 放疗药物, 安全用药, 药物相互作用","本指南深入解析结直肠恶性肿瘤化疗药及放疗辅助药的正确使用方法，帮助患者有效管理药物、规避风险，提高治疗效果！","2025-09-08 11:31:36",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]